2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...
NFL star Tom Brady has cloned his late pit bull mix, Lua, creating a new dog named Junie. Invested in biotech firm Colossal ...
TScan Therapeutics Inc. is the latest Massachusetts biotech to trim its workforce as it funnels cash resources toward its ...
Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...
A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.
Future NFL Hall of Famer Tom Brady will go to great lengths to keep the memory of his dog Lua — who died in 2023 — alive. For ...
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Portfolio manager Eden Rahim sees biotech entering a new bull market amid lower rates, better trial data and renewed investor ...
The companies Kailera Therapeutics, Summit Therapeutics, and Tubulis bagged the biggest biotech funding rounds overall in October 2025.
Former NFL quarterback Tom Brady said on Tuesday that his dog, Junie, is a clone of his late pet, Lua, who passed away two ...
Tom Brady says his dog is a clone. The six-time Super Bowl-winning quarterback and current Fox Sports broadcaster said ...
E! Online on MSN
Tom Brady Reveals His Dog Junie Is a Clone of His Late Dog Lua
Tom Brady shared that his pit bull mix Junie is a clone of his and ex-wife Gisele Bündchen's dog Lua, who died in 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback